R

    RBOT (RBOT)

    Official site

    MEDICAL DEVICES

    $0.04
    +0.00 (+10.53%)

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    39%(7/18)
    Avg Surprise
    -5.49%

    Upcoming Estimates

    Mar 31, 2026
    EPS Consensus$-1.20
    Range$-1.20 - $-1.20
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-1.76-46.7%
    60d ago$-1.33-11.3%
    30d ago$-1.33-11.3%
    7d ago$-1.22-1.3%
    Current$-1.20
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Jun 30, 2026
    EPS Consensus$-1.15
    Range$-1.15 - $-1.15
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-1.75-52.2%
    60d ago$-1.32-15.2%
    30d ago$-1.32-15.2%
    7d ago$-1.19-3.5%
    Current$-1.15
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-$-1.15---
    Mar 26EST
    		-$-1.20---
    Dec 25
    		$-1.65$-1.37-20.44%Miss+32.1%
    Sep 25
    		$-1.91$-2.33+18.03%Beat+33.4%
    Jun 25
    		$-2.23$-2.50+10.80%Beat+22.0%
    Mar 25
    		$-2.58$-2.48-4.03%Miss+4.4%
    Dec 24
    		$-2.43$-2.69+9.67%Beat-3950.0%
    Sep 24
    		$-2.87$-2.57-11.67%Miss+20.3%
    Jun 24
    		$-2.86$-2.79-2.51%Miss+40.4%
    Mar 24
    		$-2.70$-2.85+5.26%Beat+47.1%
    Dec 23
    		$-0.06$-0.12+50.00%Beat+98.8%
    Sep 23
    		$-3.60$-4.28+15.89%Beat+33.3%
    Jun 23
    		$-4.80$-4.28-12.15%Miss+0.0%
    Mar 23
    		$-5.10$-3.90-30.77%Miss-13.3%
    Dec 22
    		$-4.80$-5.40+11.11%Beat-3100.0%
    Sep 22
    		$-5.40$-4.60-17.39%Miss-100.0%
    Jun 22
    		$-4.80$-4.35-10.34%Miss-352.8%
    Mar 22
    		$-4.50$-4.08-10.29%Miss-6328.6%
    Dec 21
    		$-0.15$-0.10-50.00%Miss-14900.0%
    Sep 21
    		$-2.70$-1.80-50.00%Miss-128471.4%
    Jun 21
    		$-1.06N/AN/ABeat-
    Mar 21
    		$-0.07N/AN/ABeat-
    Dec 20
    		$-0.00N/AN/ABeat-
    Sep 20
    		$-0.00N/AN/ABeat-
    Jun 20
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.01EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC-855.63%
    Financial Health
    Debt/Equity0.10xInterest CoverageN/A
    Current Ratio1.54xQuick Ratio1.54x
    Trading Statistics
    BetaN/AAvg Volume33.06K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.04
    SMA 20$0.05
    SMA 50$0.12
    SMA 200$1.21
    EMA 10$0.04
    EMA 20$0.06
    EMA 50$0.17
    EMA 200$1.67

    MACD

    Line: -0.03Signal: -0.04Hist: 0.01

    ADX

    ADX: 61.5+DI: 6.8-DI: 31.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down76.0
    PSAR$0.03

    Bollinger Bands

    Upper Band$0.08
    Lower Band$0.03
    %B Position10606%(Upper)
    Band Width0.30

    RSI (14-Day)

    Oversold
    27.9

    Momentum Oscillators

    Stoch %K24.6
    Stoch %D22.5
    Williams %R-68.4
    ROC (10d)-30.0%
    Momentum-0.02
    CCI (20d)-66.5
    MFI (14d)16.9

    Volatility Measures

    ATR (14d)$0.01(31.8%)
    StdDev (20d)0.01
    Hist Vol122.5%(High)

    Volume Flow

    VWAP$0.04
    OBV-2.7M
    AD Line-4.8M
    CMF (20d)0.046

    Volume Metrics

    Avg Vol (20d)32.7K
    Vol Ratio1.2x
    VWMA (20d)$0.05

    Pivot Points

    R3$0.05
    R2$0.04
    R1$0.04
    Pivot Point$0.04
    S1$0.03
    S2$0.03
    S3$0.03

    Advanced Oscillators

    TSI-51.10
    Ultimate Osc61.5
    KST-613.99

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$0$0$0$0$0$2.09M$0$0$0$3.45M$0$0
    Cost of Revenue$0$291,000$0$0$0$542,000$0$0$0$525,000$0$0
    Gross Profit$0$-291,000$0$0$0$-542,000$0$0$0$-525,000$0$0
    Operating Expenses$7.50M$9.26M$11.50M$13.52M$15.75M$14.98M$17.75M$17.71M$16.11M$15.54M$21.35M$21.46M
    R&D$5.04M$7.14M$7.99M$9.05M$9.41M$8.46M$10.80M$10.92M$9.97M$8.47M$13.04M$12.71M
    SG&A$2.12M$2.63M$3.16M$4.12M$5.29M$5.54M$5.75M$5.59M$5.00M$5.87M$6.91M$7.08M
    Operating Income$-7,502,000$-9,258,000$-11,503,000$-13,519,000$-15,747,000$-14,978,000$-17,755,000$-17,713,000$-16,109,000$-15,541,000$-21,352,000$-21,458,000
    Interest Income$40,000$105,000$158,000$264,000$446,000$594,000$802,000$918,000$975,000$967,000$945,000$1.04M
    Interest Expense$0$1.26M$0$0$0$0$0$0$892,000$0$0$1,000
    Income Before Tax$-7,329,000$-10,515,000$-11,058,000$-13,215,000$-15,426,000$-13,926,000$-17,091,000$-15,205,000$-17,001,000$-13,111,000$-15,704,000$-15,334,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-7,329,000$-10,515,000$-11,058,000$-13,215,000$-15,394,000$-13,926,000$-17,091,000$-15,205,000$-17,001,000$-13,111,000$-15,704,000$-15,334,000
    EBITDA$-7,180,000$-10,339,000$-10,862,000$-13,194,000$-15,555,000$-14,261,000$-17,504,000$-15,727,000$-17,921,000$-13,793,000$-16,737,000$-16,201,000
    EBIT$-7,369,000$-10,620,000$-11,216,000$-13,479,000$-15,872,000$-14,520,000$-17,893,000$-16,123,000$-17,976,000$-14,055,000$-16,649,000$-16,377,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RBOT

    News

    Vicarious Surgical Inc. SEC Filing (Jul 27, 2026)

    Vicarious Surgical Inc. has filed a Form 15 with the SEC, indicating the termination of registration under Section 12(g) or suspension of duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The filing, accepted on July 27, 2026, was signed by CEO Stephen From and states the company relies on Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i). As of the certification date, Vicarious Surgical had approximately 31 holders of record.

    Stock Titan•7/27/26•
    Neutral

    Form DEF 14A Vicarious Surgical Inc. For: 17 July By Investing.com

    This article reports on the filing of Form DEF 14A by Vicarious Surgical Inc. for July 17th. It is a brief news item indicating a regulatory filing by the company, with no further details provided in the text. The article mentions the stock symbol RBOT, which is associated with Vicarious Surgical Inc.

    Investing.com Canada•7/17/26•
    Neutral

    Vicarious Surgical, Inc. Class A Actuals & Estimates (OTC:RBOT)

    This article provides actuals and estimates for Vicarious Surgical Inc. (RBOT) covering its financial data, stock performance, and analyst expectations. It details the company's current stock price, market capitalization, earnings per share, and upcoming earnings report date, along with historical price dynamics and volatility. The content also addresses frequently asked questions about RBOT stock, including how to buy shares and investment considerations.

    TradingView•6/26/26•
    Bearish

    Vicarious Surgical (NYSE: RBOT) plans creditor assignment and corporate dissolution

    Vicarious Surgical Inc. (NYSE: RBOT) is seeking stockholder approval to assign its assets for the benefit of creditors and then dissolve the company. The board believes this path offers the best recovery for creditors, as attempts to secure new financing or a buyer were unsuccessful, and common stockholders are unlikely to receive any distribution. As of March 31, 2026, the company reported $12.586 million in assets, $9.016 million in liabilities, and limited

    Stock Titan•6/22/26•
    Bearish

    Vicarious Surgical (RBOT) asks shareholders to approve assignment and dissolution

    Vicarious Surgical (RBOT) is seeking shareholder approval for an assignment for the benefit of creditors and a voluntary dissolution of the company. The Board believes this is the best path given recurring operating losses and inability to secure further financing, though it is unlikely current stockholders will receive a distribution after creditors are paid. The proposal also grants the Board the discretion to abandon the plan if deemed appropriate.

    Stock Titan•6/12/26•
    Bearish

    Frequently Asked Questions About RBOT

    Does RBOT pay dividends?
    RBOT (RBOT) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In